The combination of silibinin and vitamin E complex has been shown to have therapeutic effects on non‐alcoholic fatty liver disease and improve insulin sensitivity (Lv et al., 2021). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.